Imaging biomarkers in preclinical studies on brain tumors

Caroline Chung

doi:10.1007/978-94-007-7681-4_46

Imaging biomarkers in preclinical studies on brain tumors

Caroline Chung

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

There is a growing role for neuroimaging in the multidisciplinary management of brain tumors. Beyond anatomical imaging, additional functional and physiological imaging capabilities introduce the potential to interrogate characteristics of the tumor that can aid in diagnosis, guide treatment decisions, and better evaluate response to treatment in a timely manner. This chapter highlights preclinical investigation that facilitates translation of these promising functional and physiological imaging measures including perfusion and diffusion magnetic resonance imaging (MRI) and molecular and metabolic imaging with positron emission tomography (PET) and spectroscopy.

Original language	English (US)
Title of host publication	Biomarkers in Disease
Subtitle of host publication	Methods, Discoveries and Applications: Biomarkers in Cancer
Publisher	Springer Netherlands
Pages	391-413
Number of pages	23
ISBN (Electronic)	9789400776814
ISBN (Print)	9789400776807
DOIs	https://doi.org/10.1007/978-94-007-7681-4_46
State	Published - Jan 1 2015
Externally published	Yes

ASJC Scopus subject areas

General Medicine
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1007/978-94-007-7681-4_46

Cite this

@inbook{7c57aa2fab3d4046932fdf9fe0695263,

title = "Imaging biomarkers in preclinical studies on brain tumors",

abstract = "There is a growing role for neuroimaging in the multidisciplinary management of brain tumors. Beyond anatomical imaging, additional functional and physiological imaging capabilities introduce the potential to interrogate characteristics of the tumor that can aid in diagnosis, guide treatment decisions, and better evaluate response to treatment in a timely manner. This chapter highlights preclinical investigation that facilitates translation of these promising functional and physiological imaging measures including perfusion and diffusion magnetic resonance imaging (MRI) and molecular and metabolic imaging with positron emission tomography (PET) and spectroscopy.",

author = "Caroline Chung",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media Dordrecht 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-94-007-7681-4_46",

language = "English (US)",

isbn = "9789400776807",

pages = "391--413",

booktitle = "Biomarkers in Disease",

publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Imaging biomarkers in preclinical studies on brain tumors

AU - Chung, Caroline

N1 - Publisher Copyright: © Springer Science+Business Media Dordrecht 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - There is a growing role for neuroimaging in the multidisciplinary management of brain tumors. Beyond anatomical imaging, additional functional and physiological imaging capabilities introduce the potential to interrogate characteristics of the tumor that can aid in diagnosis, guide treatment decisions, and better evaluate response to treatment in a timely manner. This chapter highlights preclinical investigation that facilitates translation of these promising functional and physiological imaging measures including perfusion and diffusion magnetic resonance imaging (MRI) and molecular and metabolic imaging with positron emission tomography (PET) and spectroscopy.

AB - There is a growing role for neuroimaging in the multidisciplinary management of brain tumors. Beyond anatomical imaging, additional functional and physiological imaging capabilities introduce the potential to interrogate characteristics of the tumor that can aid in diagnosis, guide treatment decisions, and better evaluate response to treatment in a timely manner. This chapter highlights preclinical investigation that facilitates translation of these promising functional and physiological imaging measures including perfusion and diffusion magnetic resonance imaging (MRI) and molecular and metabolic imaging with positron emission tomography (PET) and spectroscopy.

UR - http://www.scopus.com/inward/record.url?scp=84943376884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943376884&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-7681-4_46

DO - 10.1007/978-94-007-7681-4_46

M3 - Chapter

AN - SCOPUS:84943376884

SN - 9789400776807

SP - 391

EP - 413

BT - Biomarkers in Disease

PB - Springer Netherlands

ER -

Imaging biomarkers in preclinical studies on brain tumors

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this